NCT00583271View on ClinicalTrials.gov

A Prospective Study of EUS Guided Celiac Block

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Chronic PancreatitisPancreatic Cancer
Interventions
DRUG

triamcinolone

80mg of triamcinolone injected into the celiac ganglion during the EUS-CB

DRUG

98% dehydrated alcohol

10ml of 98% dehydrated alcohol injected into the celiac ganglion during the EUS-CB

Trial Locations (1)

46202

Clarian Health: Indiana University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT00583271 - A Prospective Study of EUS Guided Celiac Block | Biotech Hunter | Biotech Hunter